Transition Therapeutics Report issue

For profit Phase 1 Phase 2
Founded: Toronto Canada (1987)
Status: Acquired by Opko (2016)

Organization Overview

First Clinical Trial
2005
NCT00239148
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Transition Therapeutics Inc. / Waratah Pharmaceuticals Inc. | Transition Therapeutics Ireland Limited